Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Non Operating Income (2017 - 2021)

Cogent Biosciences has reported Non Operating Income over the past 5 years, most recently at $728000.0 for Q4 2021.

  • Quarterly results put Non Operating Income at $728000.0 for Q4 2021, up 516.95% from a year ago — trailing twelve months through Dec 2021 was $3.3 million (down 55.65% YoY), and the annual figure for FY2025 was -$20000.0, down 100.1%.
  • Non Operating Income for Q4 2021 was $728000.0 at Cogent Biosciences, down from $735000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for COGT hit a ceiling of $7.2 million in Q3 2020 and a floor of $3000.0 in Q3 2018.
  • Median Non Operating Income over the past 5 years was $160000.0 (2017), compared with a mean of $665300.0.
  • Biggest five-year swings in Non Operating Income: crashed 95.71% in 2018 and later skyrocketed 7330.0% in 2021.
  • Cogent Biosciences' Non Operating Income stood at $190000.0 in 2017, then skyrocketed by 501.58% to $1.1 million in 2018, then crashed by 95.01% to $57000.0 in 2019, then skyrocketed by 107.02% to $118000.0 in 2020, then soared by 516.95% to $728000.0 in 2021.
  • The last three reported values for Non Operating Income were $728000.0 (Q4 2021), $735000.0 (Q3 2021), and $743000.0 (Q2 2021) per Business Quant data.